Financial hardship common among colon cancer patients

Financial hardship common among colon cancer patients

(HealthDay) -- Nearly 40 percent of patients undergoing adjuvant chemotherapy for stage III colon cancer experience financial hardship, even if they have health insurance coverage, according to research published online March 12 in the Journal of Clinical Oncology.

Veena Shankaran, M.D., of the University of Washington in Seattle, and colleagues conducted a study involving 555 patients with stage III , during or following adjuvant chemotherapy, who were identified using data from a population-based cancer registry. In an effort to identify those who experienced financial hardship as a direct result of their illness, participants completed a survey detailing their treatment-related costs, accrued debt, whether they were forced to sell assets or borrow money, or if they had experienced a decline in income.

The researchers found that nearly all of the 51.2 percent of patients who responded were insured during their colon cancer treatment. Overall, 38 percent reported some type of financial hardship as a consequence of their cancer treatment. Younger people and those with lower annual household incomes were more likely to report financial hardship. The factors most closely associated with treatment non-adherence were younger age, lower income, and unemployment or disability (which usually occurred following diagnosis).

"A significant proportion of patients undergoing adjuvant chemotherapy for stage III colon cancer may experience , despite having . Interventions to help at-risk patients early on during therapy may prevent long-term financial adverse effects," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)
Editorial

add to favorites email to friend print save as pdf

Related Stories

Gene signature may improve colon cancer treatment

Feb 26, 2010

A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.

Recommended for you

Blood biomarker may detect lung cancer

5 hours ago

A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer. The study abstract ...

ACG: Recent increase in incidence of young-onset CRC

21 hours ago

(HealthDay)—The incidence of young-onset colorectal cancer (CRC) is increasing, and the disease is more aggressive pathologically. These findings are being presented at the annual meeting of the American ...

User comments